Skip to main content

Table 3 Demographic and clinical data of patients with AAT deficiency

From: Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD

  PIMZ PIMS PIMI Total
N 3 1 2 6
Age (years) ÷ mean (SD) 59(16.9) 62 51(2) 56.8(12.7)
Male % 33.3 100 50 50
BMI (kg/m2) ÷ mean (SD) 22.7(0,9) 18 25(2.5) 21.2(2.3)
FEV1/FVC ÷ mean (SD) 0.48(0.2) 0.34 0.48(0.02) 0.47(0.6)
FEV1% Predicted ÷ mean (SD) 46.5(2.1) 40 48.5(0.7) 48(4.5)
FVC(%) ÷ mean (SD) 51.3(4.05) 47 49.5(3.5) 2.9(0.2)
MRC (score) ÷ mean (SD) 2 3 2 2.3 (0.5)
CAT (score) ÷ mean (SD) 29.5(2.1) 40 34.5(6.3) 34.3 (9.9)
Current/former/non smoker (%) 0/33,3/0 0/0/0 50/0/0 16,6/16,6/0
Pack/year ÷ (years) mean (SD) 20 0 34 27(7)